Synergetic anticancer effect of combined quercetin and recombinant adenoviral vector expressing human wild-type p53, GM-CSF and B7-1 genes on hepatocellular carcinoma cells in vitro

World Journal of Gastroenterology

Volumn 9, Issue 1, 2003, Pages 73-78

  Shi, Ming ^a   Wang, Fu Sheng ^a   Wu, Zu Ze ^b  

^a BEIJING 302 HOSPITAL   (China)

^b BEIJING INSTITUTE OF RADIATION MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ADENOVIRUS VECTOR; DNA NUCLEOTIDYLEXOTRANSFERASE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; PROTEIN; PROTEIN B7 1; PROTEIN P53; QUERCETIN; TRYPAN BLUE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; ASSAY; CANCER CELL CULTURE; CANCER INHIBITION; CELL PROLIFERATION; CELL VIABILITY; CHEMOSENSITIVITY; CONTROLLED STUDY; DRUG EFFECT; ELECTROPHORESIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE; GENE EXPRESSION; GENE THERAPY; HUMAN; HUMAN CELL; IN VITRO STUDY; LIVER CELL CARCINOMA; MULTIMODALITY CANCER THERAPY; RECOMBINANT GENE; WESTERN BLOTTING; WILD TYPE;

EID: 0037439174     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v9.i1.73     Document Type: Article

References (62)

1. Venook AP. Hepatocellular carcinoma. Curr Treat Options Oncol 2000; 1: 407-415
2. Mohr L, Geissler M, Blum HE. Gene therapy for malignant liver disease. Expert Opin Biol Ther 2002; 2: 163-175
3. Peller S. Clinical implications of p53: Effect on prognosis, tumor progression and chemotherapy response. Semin Cancer Biol 1998; 8: 379-387
4. Friess H, Kleeff J, Korc M, Buchler MW. Molecular aspects of pancreatic cancer and future perspectives. Dig Surg 1999; 16: 281-290
5. Rocco JW, Sidransky D. p16(MTS-1/CDKN2/INK4a) in cancer progression. Exp Cell Res 2001; 264: 42-55
6. Canote R, Du Y, Carling T, Tian F, Peng Z, Huang S. The tumor suppressor gene RIZ in cancer gene therapy (review). Oncol Rep 2002; 9: 57-60
7. Farid NR. P53 mutations in thyroid carcinoma: Tidings from an old foe. J Endocrinol Invest 2001; 24: 536-545
8. Muschen M, Warskulat U, Beckmann MW. Defining CD95 as a tumor suppressor gene. J Mol Med 2000; 78: 312-325
9. Behrens J. Cadherins and catenins: Role in signal transduction and tumor progression. Cancer Metastasis Rev 1999; 18: 15-30
10. Wu Q, Moyana T, Xiang J. Cancer gene therapy by adenovirus-mediated gene transfer. Curr Gene Ther 2001; 1: 101-122
11. Xu GW, Sun ZT, Forrester K, Wang XW, Coursen J, Harris CC. Tissue-specific growth suppression and chemosensitivity promotion in human hepatocellular carcinoma cells by retroviral-mediated transfer of the wild-type p53 gene. Hepatology 1996; 24: 1264-1268
12. Qin LX, Tang ZY. The prognostic molecular markers in hepatocellular carcinoma. World J Gastroenterol 2002; 8: 385-392
13. Buendia MA. Genetics of hepatocellular carcinoma. Semin Cancer Biol 2000; 10: 185-200
14. Yu JS, Burwick JA, Dranoff G, Breakefield XO. Gene therapy for metastatic brain tumors by vaccination with granulocyte-macrophage colony-stimulating factor-transduced tumor cells. Hum Gene Ther 1997; 8: 1065-1072
15. Hogge GS, Burkholder JK, Culp J, Albertini MR, Dubielzig RR, Keller ET, Yang NS, MacEwen EG. Development of human granulocyte-macrophage colony-stimulating factor-transfected tumor cell vaccines for the treatment of spontaneous canine cancer. Hum Gene Ther 1998; 9: 1851-1861
16. Lu L, Hsieh M, Oriss TB, Morel PA, Starzl TE, Rao AS, Thomson AW. Generation of DC from mouse spleen cell culture in response to GM-CSF: Immunophenotypic and functional analyses. Immunology 1995; 84: 127-134
17. Ogawa T, Kusumoto M, Mizumoto K, Sato N, Tanaka M. Adenoviral GM-CSF gene transduction into breast cancer cells induced long-lasting antitumor immunity in mice. Breast Cancer 1999; 6: 301-304
18. Felzmann T, Ramsey WJ, Blaese RM. Anti-tumor immunity generated by tumor cells engineered to express B7-1 via retroviral or adenoviral gene transfer. Cancer Lett 1999; 135: 1-10
19. Horig H, Lee DS, Conkright W, Divito J, Hasson H, LaMare M, Rivera A, Park D, Tine J, Guito K, Tsang KW, Schlom J, Kaufman HL. Phase I clinical trial of a recombinant canarypoxvirus (ALVAC) vaccine expressing human carcinoembryonic antigen and the B7.1 co-stimulatory molecule. Cancer Immunol Immunother 2000; 49: 504-514
20. Takahashi T, Hirano N, Takahashi T, Chiba S, Yazaki Y, Hirai H. Immunogene therapy against mouse leukemia using B7 molecules. Cancer Gene Ther 2000; 7: 144-150
21. Nakatsuka K, Sugiyama H, Nakagawa Y, Takahashi H. Purification of antigenic peptide from murine hepatoma cells recognized by class-I major histocompatibility complex molecule-restricted cytotoxic T-lymphocyte induced with B7-1-gene-transfected hepatoma cells. J Hepatol 1999; 30: 1119-1129
22. Kim KY, Kang MA, Nam MJ. Enhancement of natural killer cell-mediated cytotoxicity by coexpression of GM-CSF/B70 in hepatoma. Cancer Lett 2001; 166: 33-40
23. Qiu ZH, Lao MF, Wu ZZ. Construction of recombinant adenovirus co-expressing human wild-type p53, GM-CSF and B7-1 genes. Zhongguo Shengwuhuaxue Yu Fengzishengwu Xuebao 2001; 17: 33-38
24. Qiu ZH, Lao MF, Wang YF, Wu ZZ. Adenovirus mediate multigenes expressing in lung cancer and inducing apoptosis. Zhongguo Zhongliu Shengwuzhiliao Zazhi 1999; 6: 83-86
25. Qiu ZH, Lao MF, Wu ZZ. Co-transfer of human wild-type p53 and granulocyte-macrophage colony-stimulating factor genes via recombinant adenovirus induces apoptosis and enhances immunogenicity in laryngeal cancer cells. Cancer Lett 2001; 167: 25-32
26. Larocca LM, Teofili L, Sica S, Piantelli M, Maggiano N, Leone G, Ranelletti FO. Quercetin inhibits the growth of leukemic progenitors and induces the expression of transforming growth factor-beta 1 in these cells. Blood 1995; 85: 3654-3661
27. Scambia G, Panici PB, Ranelletti FO, Ferrandina G, De Vincenzo R, Piantelli M, Masciullo V, Bonanno G, Isola G, Mancuso S. Quercetin enhances transforming growth factor beta 1 secretion by human ovarian cancer cells. Int J Cancer 1994; 57: 211-215
28. Ranelletti FO, Ricci R, Larocca LM, Maggiano N, Capelli A, Scambia G, Benedetti-Panici P, Mancuso S, Rumi C, Piantelli M. Growth-inhibitory effect quercetin and presence of type II estrogen-binding sites in human colon-cancer cell lines and primary colomrectal tumors. Int J Cancer 1992; 50: 486-492
29. Choi JA, Kim JY, Lee JY, Kang CM, Kwon HJ, Yoo YD, Kim TW, Lee YS, Lee SJ. Induction of cell cycle arrest and apoptosis in human breast cancer cells by quercetin. Int J Oncol 2001; 19: 837-844
30. Pawlikowska-Pawlega B, Jakubowicz-Gil J, Rzymowska J, Gawron A. The effect of quercetin on apoptosis and necrosis induction in human colon adenocarcinoma cell line LS180. Folia Histochem Cytobiol 2001; 39: 217-218
31. Kampa M, Hatzoglou A, Notas G, Damianaki A, Bakogeorgou E, Gemetzi C, Kouroumalis E, Martin PM, Castanas E. Wine antioxidant polyphenols inhibit the proliferation of human prostate cancer cell lines. Nutr Cancer 2000; 37: 223-233
32. Iwashita K, Kobori M, Yamaki K, Tsuchida T. Flavonoids inhibit cell growth and induce apoptosis in B16 melanoma and 4A5 cells. Biosci Biotechnol Biochem 2000; 64: 1813-1820
33. Uddin S, Choudhry MA. Quercetin, a bioflavonoid, inhibits the DNA synthesis of human leukemia cells. Biochem Mol Biol Int 1995; 36: 545-550
34. Caltagirone S, Rossi C, Poggi A, Ranelletti FO, Natali PG, Brunetti M, Aiello FB, Piantelli M. Flavonoids apigenin and quercetin inhibit melanoma growth and metastatic potential. Int J Cancer 2000; 87: 595-600
35. Sliutz G, Karlseder J, Tempfer C, Orel L, Holzer G, Simon MM. Drug resistance against gemcitabine and topotecan mediated by constitutive hsp70 overexpression in vitro: Implication of quercetin as sensitiser in chemotherapy. Br J Cancer 1996; 74: 172-177
36. Yang CS, Landau JM, Huang MT, Newmark HL. Inhibition of carcinogenesis by dietary polyphenolic compounds. Annu Rev Nutr 2001; 21: 381-406
37. Wang HK. The therapeutic potential of flavonoids. Expert Opin Investig Drugs 2000; 9: 2103-2119
38. Asaum J, Matsuzaki H, Kawasak S, Kuroda M, Takeda Y, Kishi K, Hiraki Y. Effects of quercetin on the cell growth and the intracellular accumulation and retention of adriamycin. Anticancer Res 2000; 20: 2477-2483
39. Damianaki A, Bakogeorgou E, Kampa M, Notas G, Hatzoglou A, Panagiotou S, Gemetzi C, Kouroumalis E, Martin PM, Castanas E. Potent inhibitory action of red wine polyphenols on human breast cancer cells. J Cell Biochem 2000; 78: 429-441
40. Yamashita N, Kawanishi S. Distinct mechanisms of DNA damage in apoptosis induced by quercetin and luteolin. Free Radic Res 2000; 33: 623-633
41. Musonda CA, Helsby N, Chipman JK. Effects of quercetin on drug metabolizing enzymes and oxidation of 2′,7-dichlorofluorescin in HepG2 cells. Hum Exp Toxicol 1997; 16: 700-708
42. Exon JH, Magnuson BA, South EH, Hendrix K. Dietary quercetin, immune functions and colonic carcinogenesis in rats. Immunopharmacol Immunotoxicol 1998; 20: 173-190
43. Drewa G, Wazqak A, Palgan K, Schachtschabel DO, Grzanka A, Sujkowska R. Influence of quercetin on B16 melanotic melanoma growth in C57BL/6 mice and on activity of some acid hydrolases in melanoma tissue. Neoplasma 2001; 48: 12-18
44. Weber G, Shen F, Yang H, Prajda N, Li W. Regulation of signal transduction activity in normal and cancer cells. Anticancer Res 1999; 19: 3703-3709
45. Weber G, Shen F, Prajda N, Yeh YA, Yang H, Herenyiova M, Look KY. Increased signal transduction activity and down-regulation in human cancer cells. Anticancer Res 1996; 16: 3271-3282
46. Richter M, Ebermann R, Marian B. Quercetin-induced apoptosis in colorectal tumor cells: Possible role of EGF receptor signaling. Nutr Cancer 1999; 34: 88-99
47. Shen F, Herenyiova M, Weber G. Synergistic down-regulation of signal transduction and cytotoxicity by tiazofurin and quercetin in human ovarian carcinoma cells. Life Sci 1999; 64: 18690-1876
48. Levine AJ. p53, the cellular gatekeeper for growth and division. Cell 1997; 88: 323-331
49. Greenbalt MS, Bennett WP, Hollstein M, Harris CC. Mutation in the P53 tumor supressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 1994; 54: 4855-4878
50. Hui AM, Makuuchi M, Li X. Cell cycle regulators and human hepatocarcinogenesis. Hepatogastroenterology 1998; 45: 1635-1642
51. Yang CS, Landau JM, Huang MT, Newmark HL. Inhibition of carcinogenesis by dietary polyphenolic compounds. Annu Rev Nutr 2001; 21: 381-406
52. Hollman PC, Katan MB. Health effects and bioavailability of dietary flavonols. Free Radic Res 1999; 31 (Suppl): S75-80
53. Avila MA, Velasco JA, Cansado J, Notario V. Quercetin mediate the down-regulation of mutation p53 in the human breast cancer call line MDA-MB468. Cancer Research 1994; 54: 2424-2428
54. Thottassery, Zambetti GP, Arimori K, Schuetz EG, Schuetz JD. p53-dependent regulation of mdr1 gene expression causes selective resistance to chemotherapeutic agents. Proc Natl Sci USA 1997; 94: 11037-11042
55. Wang D, Shi JQ. Overexpression and mutations of tumor suppressor gene p53 in hepatocellular carcinoma. China Natl J New Gastroenterol 1996; 2: 161-164
56. Wang XJ, Yuan SL, Li CP, Iida N, Oda H, Aiso S, Ishikawa T. Infrequent p53 gene mutation and expression of the cardia adenocarcinomas from a high incidence area of Southwest China. Shijie Huaren Xiaohua Zazhi 2000; 6: 750-753
57. Li ZX, Liu PY, Xu WX, Cong B, Ma ZX, Li Y. p53 gene mutations in primary gastric cancer. China Natl J New Gastroenterol 1996; 2: 41-43
58. Peng XM, Peng WW, Yao JL. Codon 249 mutations of p53 gene in development of hepatocellular carcinoma. World J Gastroenterol 1998; 4: 125-127
59. Scambia G, Ranelletti FO, Panici PB, De Vincenzo R, Bonanno G, Ferrandina G, Piantelli M, Bussa S, Rumi C, Cianfriglia M. Quercetin potentiates the effect of adriamycin in a multidrug-resistant MCF-7 human breast-cancer cell line: P-glycoprotein as a possible target. Cancer Chemother Pharmacol 1994; 34: 459-464
60. Beniston RG, Morgan IM, O'Brien V, Campo MS. Quercetin, E7 and p53 in papillomavirus oncogenic cell transformation. Carcinogenesis 2001; 22: 1069-1076
61. Wei YQ, Zhao X, Kariya Y, Fukata H, Teshigawara K, Uchida A. Induction of apoptosis by quercetin: Involvement of heat shock protein. Cancer Research 1994; 54:4952-4957
62. Shi M, Wang FS, Liu MX, Jin L, Shi H, Lei ZY. The examination of p53 gene status in BEL-7402, HLE and HuH-7 cells. Shijie Huaren Xiaohua Zazhi 2001; 9: 1330-1332